Basic Information
RNALocate ID: | RLID:11001949 |
RNA Symbol: | hsa-miR-185-5p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-185 |
RNA ID: | miRBase:MIMAT0000455 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001842 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001843 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001844 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001845 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001942 | Exosome | Plasma | 29130611 |
RLID:11001943 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001944 | Exosome | Breast milk | 22211110 |
RLID:11001945 | Exosome | Brain tissue | 23382797 |
RLID:11001946 | Exosome | Plasma | 23663360 |
RLID:11001947 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001948 | Exosome | Serum | 25135963 |
RLID:11001950 | Microvesicle | Plasma | 23077538 |
RLID:11001951 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001952 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000100 | Exosome | Blood|Tongue tissue | |
RLID-D:11000383 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-185-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-20977 |
MNDR | hsa-miR-185-5p | Medulloblastoma | MNDR-E-MI-20978 |
MNDR | hsa-miR-185-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-20979 |
MNDR | hsa-miR-185-5p | Lymphoma | MNDR-E-MI-20980 |
MNDR | hsa-miR-185-5p | Cutaneous t cell lymphoma | MNDR-E-MI-20981 |
MNDR | hsa-miR-185-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20982 |
MNDR | hsa-miR-185-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-20983 |
MNDR | hsa-miR-185-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20984 |
MNDR | hsa-miR-185-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-20985 |
MNDR | hsa-miR-185-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20986 |
MNDR | hsa-miR-185-5p | Breast cancer luminal | MNDR-E-MI-20987 |
MNDR | hsa-miR-185-5p | Anencephaly | MNDR-E-MI-20988 |
MNDR | hsa-miR-185-5p | Neurofibromatosis 1 | MNDR-E-MI-20989 |
MNDR | hsa-miR-185-5p | Prostate cancer | MNDR-E-MI-20990 |
MNDR | hsa-miR-185-5p | Prostate carcinoma | MNDR-E-MI-20991 |
MNDR | hsa-miR-185-5p | Gastric cancer | MNDR-E-MI-20992 |
MNDR | hsa-miR-185-5p | Wolfram syndrome | MNDR-E-MI-20993 |
MNDR | hsa-miR-185-5p | Alzheimer disease | MNDR-E-MI-20994 |
MNDR | hsa-miR-185-5p | Intracranial aneurysm | MNDR-E-MI-20995 |
MNDR | hsa-miR-185-5p | Esophageal carcinoma | MNDR-E-MI-20996 |
MNDR | hsa-miR-185-5p | Dysautonomia familial | MNDR-E-MI-20997 |
MNDR | hsa-miR-185-5p | Polycystic ovary syndrome | MNDR-E-MI-20998 |
MNDR | hsa-miR-185-5p | Head and neck cancer | MNDR-E-MI-20999 |
MNDR | hsa-miR-185-5p | Cardiovascular disease | MNDR-E-MI-21000 |
MNDR | hsa-miR-185-5p | Moyamoya disease | MNDR-E-MI-21001 |
MNDR | hsa-miR-185-5p | Lung cancer | MNDR-E-MI-21002 |
MNDR | hsa-miR-185-5p | Parkinson disease | MNDR-E-MI-21003 |
MNDR | hsa-miR-185-5p | Breast cancer | MNDR-E-MI-21004 |
MNDR | hsa-miR-185-5p | Pituitary neoplasms | MNDR-E-MI-21005 |
MNDR | hsa-miR-185-5p | Pancreatic cancer | MNDR-E-MI-21006 |
MNDR | hsa-miR-185-5p | Malignant melanoma | MNDR-E-MI-21007 |
MNDR | hsa-miR-185-5p | Rectum adenocarcinoma | MNDR-E-MI-21008 |
MNDR | hsa-miR-185-5p | Nephroblastoma | MNDR-E-MI-21009 |
MNDR | hsa-miR-185-5p | Colon cancer | MNDR-E-MI-21010 |
MNDR | hsa-miR-185-5p | Colon adenocarcinoma | MNDR-E-MI-21011 |
MNDR | hsa-miR-185-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21012 |
MNDR | hsa-miR-185-5p | Ovarian cancer | MNDR-E-MI-21013 |
MNDR | hsa-miR-185-5p | Acromegaly | MNDR-E-MI-21014 |
MNDR | hsa-miR-185-5p | Carcinoma ductal breast | MNDR-E-MI-21015 |
MNDR | hsa-miR-185-5p | Glioblastoma | MNDR-E-MI-21016 |
MNDR | hsa-miR-185-5p | Glioma | MNDR-E-MI-21017 |
MNDR | hsa-miR-185-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-21018 |
MNDR | hsa-miR-185-5p | Chordoma | MNDR-E-MI-21019 |
MNDR | hsa-miR-185-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21020 |
MNDR | hsa-miR-185-5p | Osteosarcoma | MNDR-E-MI-21021 |
MNDR | hsa-miR-185-5p | Liposarcoma | MNDR-E-MI-21022 |
MNDR | hsa-miR-185-5p | Meningioma | MNDR-E-MI-21023 |
MNDR | hsa-miR-185-5p | Liver cancer | MNDR-E-MI-21024 |
MNDR | hsa-miR-185-5p | Uterine cancer | MNDR-E-MI-21025 |
MNDR | hsa-miR-185-5p | Cervical adenocarcinoma | MNDR-E-MI-21026 |
MNDR | hsa-miR-185-5p | Gastric adenocarcinoma | MNDR-E-MI-21027 |
MNDR | hsa-miR-185-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21028 |
MNDR | hsa-miR-185-5p | Pituitary adenoma | MNDR-E-MI-21029 |
MNDR | hsa-miR-185-5p | Lung squamous cell carcinoma | MNDR-E-MI-21030 |
MNDR | hsa-miR-185-5p | Non-small cell lung cancer | MNDR-E-MI-21031 |
MNDR | hsa-miR-185-5p | Lung adenocarcinoma | MNDR-E-MI-21032 |
MNDR | hsa-miR-185-5p | Thyroid carcinoma | MNDR-E-MI-21033 |
MNDR | hsa-miR-185-5p | Bladder urothelial carcinoma | MNDR-E-MI-21034 |
MNDR | hsa-miR-185-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-21035 |
MNDR | hsa-miR-185-5p | Carcinoma renal cell | MNDR-E-MI-21036 |
MNDR | hsa-miR-185-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21037 |
MNDR | hsa-miR-185-5p | Clear cell renal cell carcinoma | MNDR-E-MI-21038 |
MNDR | hsa-miR-185-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-21039 |
MNDR | hsa-miR-185-5p | Large cell carcinoma | MNDR-E-MI-21040 |
MNDR | hsa-miR-185-5p | Esophageal cancer | MNDR-E-MI-21041 |
MNDR | hsa-miR-185-5p | Liver cirrhosis | MNDR-E-MI-21042 |
MNDR | hsa-miR-185-5p | Oncocytoma | MNDR-E-MI-21043 |
MNDR | hsa-miR-185-5p | Stomach carcinoma | MNDR-E-MI-21044 |
MNDR | hsa-miR-185-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21045 |
MNDR | hsa-miR-185-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-21046 |
MNDR | hsa-miR-185-5p | Fibromyalgia | MNDR-E-MI-21047 |
MNDR | hsa-miR-185-5p | Encephalomyelitis | MNDR-E-MI-21048 |
MNDR | hsa-miR-185-5p | Breast invasive carcinoma | MNDR-E-MI-21049 |
MNDR | hsa-miR-185-5p | Early hepatocellular carcinoma | MNDR-E-MI-21050 |
MNDR | hsa-miR-185-5p | Malignant pleural mesothelioma | MNDR-E-MI-21051 |
MNDR | hsa-miR-185-5p | Retinoblastoma | MNDR-E-MI-21052 |
MNDR | hsa-miR-185-5p | Neuroblastoma | MNDR-E-MI-21053 |
MNDR | hsa-miR-185-5p | Hodgkin lymphoma | MNDR-E-MI-21054 |
MNDR | hsa-miR-185-5p | Dementia vascular | MNDR-E-MI-21055 |
MNDR | hsa-miR-185-5p | Tonsil cancer | MNDR-E-MI-21056 |
MNDR | hsa-miR-185-5p | Psoriasis | MNDR-E-MI-21057 |
MNDR | hsa-miR-185-5p | Acute myelocytic leukemia | MNDR-E-MI-21058 |
MNDR | hsa-miR-185-5p | Colorectal cancer | MNDR-E-MI-21059 |
MNDR | hsa-miR-185-5p | Multiple myeloma | MNDR-E-MI-21060 |
MNDR | hsa-miR-185-5p | Ependymoma | MNDR-E-MI-21061 |
MNDR | hsa-miR-185-5p | Hearing loss noise-induced | MNDR-E-MI-21062 |
MNDR | hsa-miR-185-5p | Cardiomegaly | MNDR-E-MI-21063 |
MNDR | hsa-miR-185-5p | Sleep deprivation | MNDR-E-MI-21064 |
MNDR | hsa-miR-185-5p | Epstein-barr virus infections | MNDR-E-MI-21065 |
MNDR | hsa-miR-185-5p | Stroke lacunar | MNDR-E-MI-21066 |
MNDR | hsa-miR-185-5p | Breast cancer her3+ negative | MNDR-E-MI-21067 |
MNDR | hsa-miR-185-5p | High grade dysplastic nodule | MNDR-E-MI-21068 |
MNDR | hsa-miR-185-5p | HPV | MNDR-E-MI-21069 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG4 | Homo sapiens | RR00024860 |
TOP